Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) EBT Margin (2016 - 2025)

Immucell (ICCC) has disclosed EBT Margin for 16 consecutive years, with 2.46% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin rose 1034.0% year-over-year to 2.46%, compared with a TTM value of 8.42% through Sep 2025, up 2872.0%, and an annual FY2024 reading of 8.1%, up 2492.0% over the prior year.
  • EBT Margin was 2.46% for Q3 2025 at Immucell, down from 7.82% in the prior quarter.
  • Across five years, EBT Margin topped out at 17.96% in Q1 2025 and bottomed at 67.13% in Q1 2023.
  • Average EBT Margin over 5 years is 11.46%, with a median of 8.38% recorded in 2024.
  • The sharpest move saw EBT Margin crashed -7570bps in 2023, then skyrocketed 6111bps in 2024.
  • Year by year, EBT Margin stood at 1.38% in 2021, then tumbled by -3182bps to 42.61% in 2022, then skyrocketed by 59bps to 17.41% in 2023, then soared by 139bps to 6.72% in 2024, then crashed by -137bps to 2.46% in 2025.
  • Business Quant data shows EBT Margin for ICCC at 2.46% in Q3 2025, 7.82% in Q2 2025, and 17.96% in Q1 2025.